PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Increased selectivity and efficacy in photochemotherapy may be achieved by the use of monoclonal antibodies (Mabs) bound to chromophores. Due to their antigen recognition capabilities, Mabs can potentially deliver higher concentrations of chromophores to target tissue while sparing normal tissue. A brief review of the current status of antibody-mediated selective phototoxicity is presented.
T. Hasan
"Selective Phototoxicity Using Monoclonal Antibody-Chromophore Conjugates", Proc. SPIE 0997, Advances in Photochemotherapy, (17 March 1989); https://doi.org/10.1117/12.960183
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
T. Hasan, "Selective Phototoxicity Using Monoclonal Antibody-Chromophore Conjugates," Proc. SPIE 0997, Advances in Photochemotherapy, (17 March 1989); https://doi.org/10.1117/12.960183